Immunotech Biopharm Ltd

SEHK:6978 Stock Report

Market Cap: HK$1.7b

Immunotech Biopharm Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Yu Wang

Chief executive officer

CN¥2.6m

Total compensation

CEO salary percentage100.0%
CEO tenure5.4yrs
CEO ownershipn/a
Management average tenure4.8yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Will Immunotech Biopharm (HKG:6978) Spend Its Cash Wisely?

Dec 30
Will Immunotech Biopharm (HKG:6978) Spend Its Cash Wisely?

We're Hopeful That Immunotech Biopharm (HKG:6978) Will Use Its Cash Wisely

Apr 29
We're Hopeful That Immunotech Biopharm (HKG:6978) Will Use Its Cash Wisely

CEO Compensation Analysis

How has Yu Wang's remuneration changed compared to Immunotech Biopharm's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥3mCN¥3m

-CN¥335m

Sep 30 2023n/an/a

-CN¥315m

Jun 30 2023n/an/a

-CN¥296m

Mar 31 2023n/an/a

-CN¥307m

Dec 31 2022CN¥4mCN¥4m

-CN¥318m

Sep 30 2022n/an/a

-CN¥333m

Jun 30 2022n/an/a

-CN¥347m

Mar 31 2022n/an/a

-CN¥351m

Dec 31 2021CN¥38mCN¥3m

-CN¥354m

Compensation vs Market: Yu's total compensation ($USD354.73K) is about average for companies of similar size in the Hong Kong market ($USD341.27K).

Compensation vs Earnings: Yu's compensation has been consistent with company performance over the past year.

CEO

Yu Wang (55 yo)

5.4yrs

Tenure

CN¥2,563,000

Compensation

Dr. Yu Wang serves as the Chief Executive Officer and Chief Technology Officer at Immunotech Biopharm Ltd. since December 2018 and also serves as its Director. Dr. Wang has experience in medical research....

Leadership Team

NamePositionTenureCompensationOwnership
Zheng Tan
Executive Chairman6.1yrsCN¥2.67m46.69%
CN¥ 785.7m
Yu Wang
CEO, CTO & Executive Director5.4yrsCN¥2.56mno data
Hyun Chul Jung
Founder & Chief Strategy Officerno dataCN¥607.00k8.71%
CN¥ 146.6m
Ning Yang
CFO & Company Secretary2.8yrsno datano data
Yu Zhang
Chief Scientistno datano datano data
Jian Zhang
Senior Vice Presidentno datano datano data

4.8yrs

Average Tenure

53.5yo

Average Age

Experienced Management: 6978's management team is considered experienced (4.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Zheng Tan
Executive Chairman6.1yrsCN¥2.67m46.69%
CN¥ 785.7m
Yu Wang
CEO, CTO & Executive Directorno dataCN¥2.56mno data
Chi Kit Ng
Independent Non-Executive Director3.9yrsCN¥268.00kno data
Donghu Wang
Non-Executive Directorless than a yearno datano data
Ran Tao
Non-Executive Director2.8yrsno datano data
Yingdian Wang
Independent Non-Executive Director3.9yrsCN¥275.00kno data
Sujiu Peng
Independent Non-Executive Director3.9yrsCN¥275.00kno data
Ruihua Wang
Non-Executive Director1.2yrsno datano data
Fan Yang
Non-Executive Director1.2yrsno datano data

3.3yrs

Average Tenure

55yo

Average Age

Experienced Board: 6978's board of directors are considered experienced (3.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.